Prevelance of Cutaneous Disorders in Patients with Polycystic Ovary Syndrome
Randa Zakarya Ramadan;
Abstract
Women with Polycystic Ovary Syndrome (PCOS) present with either a history of irregular menstrual cycles, clinical signs or biochemical parameters suggestive of elevated androgen levels. Because of the inconsistency in clinical presentation, medical advice is sought from gynaecologists, endocrinologists or dermatologists.
The current definition of PCOS is based on Rotterdam consensus meeting (2004). It defines the syndrome as presence of any two of the following three criteria: (1) Menstrual irregularity: Oligomenorrhoea and/or anovulation, (2) Clinical (Acne or Hirsutism) and/or biochemical Hyperandrogenemia, and (3) PCOS on ultrasonography. Excessive LH secretion relative to FSH was the first laboratory abnormality identified in classic PCOS. It is thought to play a role in the pathogenesis of PCOS by increasing androgen production and secretion by
The current definition of PCOS is based on Rotterdam consensus meeting (2004). It defines the syndrome as presence of any two of the following three criteria: (1) Menstrual irregularity: Oligomenorrhoea and/or anovulation, (2) Clinical (Acne or Hirsutism) and/or biochemical Hyperandrogenemia, and (3) PCOS on ultrasonography. Excessive LH secretion relative to FSH was the first laboratory abnormality identified in classic PCOS. It is thought to play a role in the pathogenesis of PCOS by increasing androgen production and secretion by
Other data
| Title | Prevelance of Cutaneous Disorders in Patients with Polycystic Ovary Syndrome | Authors | Randa Zakarya Ramadan | Issue Date | 2018 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.